CIK: 0001056807
Total reported value
$3.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | 2655787D | Blueprint Medicines CORP | Stock-Other | 12.49% | — | +9.66% | |
| 2 | CYTK | Cytokinetics INC | Stock-Healthcare | 10.09% | — | +14.94% | |
| 3 | CCXIEUR | Chemocentryx INC | Stock-Other | 7.83% | — | — | |
| 4 | EXEL 4.25 08-15-19 | Exelixis INC | Stock-Healthcare | 7.23% | — | — | |
| 5 | CNCEEUR | Concert Pharmaceuticals INC | Stock-Other | 6.59% | — | — | |
| 6 | ARRYEUR | Array Biopharma INC | Stock-Other | 6.27% | — | +5.23% | |
| 7 | FWRD | Forward Air Corporation | Stock-Other | 5.51% | — | -1.16% | |
| 8 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 4.22% | — | — | |
| 9 | GLYCEUR | Glycomimetics INC | Stock-Other | 3.79% | — | — | |
| 10 | ✓ | Cascadian Therapeutics INC | Stock-Other | 3.78% | — | — | |
| 11 | ✓ | Oncomed Pharmaceuticals INC | Stock-Other | 3.51% | — | — | |
| 12 | ✓ | Tobira Therapeutics Inc | Stock-Other | 3.35% | — | — | |
| 13 | ✓ | Cti Biopharma CORP | Stock-Other | 3.24% | — | — | |
| 14 | ARQLUSD | Arqule INC | Stock-Other | 3.02% | — | -5.61% | |
| 15 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 2.24% | — | — | |
| 16 | ✓ | Nivalis Therapeutics INC | Stock-Other | 1.89% | — | +24.55% | |
| 17 | ✓ | Vitae Pharmaceuticals INC | Stock-Other | 1.75% | — | -63.57% | |
| 18 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 1.70% | — | — | |
| 19 | INFIQ | Infinity Pharmaceuticals INC | Stock-Other | 1.47% | — | — | |
| 20 | ✓ | Gtx INC Del | Stock-Other | 1.35% | — | — | |
| 21 | CTMX | Cytomx Therapeutics INC | Stock-Other | 1.32% | — | — | |
| 22 | ADROEUR | Chinook Therapeutics INC | Stock-Other | 1.24% | — | — | |
| 23 | MGNX | Macrogenics INC | Stock-Other | 1.15% | — | — | |
| 24 | ESPR | Esperion Therapeutics INC | Stock-Other | 1.05% | — | -17.74% | |
| 25 | ✓ | Pain Therapeutics INC | Stock-Other | 1.00% | — | — | |
| 26 | ✓ | Qlt INC | Stock-Other | 0.68% | — | -60.44% | |
| 27 | ✓ | Sunesis Pharmaceuticals INC | Stock-Other | 0.56% | — | — | |
| 28 | ✓ | Orexigen Therapeutics INC | Stock-Other | 0.48% | — | — | |
| 29 | ✓ | Mast Therapeutics INC | Stock-Other | 0.37% | — | — | |
| 30 | ✓ | Catalyst Biosciences INC | Stock-Other | 0.31% | — | — | |
| 31 | GBIM | Globeimmune INC | Stock-Other | 0.27% | — | — | |
| 32 | CALAEUR | Calithera Biosciences INC | Stock-Other | 0.10% | — | -25.48% | |
| 33 | PIRSEUR | Pieris Pharmaceuticals INC | Stock-Other | 0.08% | — | — | |
| 34 | ✓ | Aviragen Therapeutics INC | Stock-Other | 0.06% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CCXIEUR | Chemocentryx INC | +2.8% | — | Unchanged |
| 2 | CYTK | Cytokinetics INC | +2.5% | +14.94% | Add |
| 3 | EXEL 4.25 08-15-19 | Exelixis INC | +1.6% | — | Unchanged |
| 4 | ✓ | Tobira Therapeutics Inc | +0.8% | — | Unchanged |
| 5 | 2655787D | Blueprint Medicines CORP | +0.7% | +9.66% | Add |
| 6 | ARRYEUR | Array Biopharma INC | +0.5% | +5.23% | Add |
| 7 | ✓ | Nivalis Therapeutics INC | +0.3% | +24.55% | Add |
| 8 | ✓ | Oncomed Pharmaceuticals INC | +0.2% | — | Unchanged |
| 9 | ✓ | Mast Therapeutics INC | +0.1% | — | Unchanged |
| 10 | ✓ | Gtx INC Del | -0.1% | — | Unchanged |
| 11 | GBIM | Globeimmune INC | -0.1% | — | Unchanged |
| 12 | ✓ | Sunesis Pharmaceuticals INC | -0.1% | — | Unchanged |
| 13 | ✓ | Catalyst Biosciences INC | -0.1% | — | Unchanged |
| 14 | ARQLUSD | Arqule INC | -0.1% | -5.61% | Trim |
| 15 | CALAEUR | Calithera Biosciences INC | -0.1% | -25.48% | Trim |
| 16 | ✓ | Pain Therapeutics INC | -0.2% | — | Unchanged |
| 17 | FWRD | Forward Air Corporation | -0.6% | -1.16% | Trim |
| 18 | CTMX | Cytomx Therapeutics INC | -0.6% | — | Unchanged |
| 19 | XENE | Xenon Pharmaceuticals INC | -0.8% | — | Unchanged |
| 20 | ESPR | Esperion Therapeutics INC | -1.5% | -17.74% | Trim |
| 21 | ✓ | Vitae Pharmaceuticals INC | -1.7% | -63.57% | Trim |
| 22 | ✓ | Qlt INC | -2.1% | -60.44% | Trim |
| 23 | ✓ | Cti Biopharma CORP | -2.7% | — | Unchanged |
| 24 | CNCEEUR | Concert Pharmaceuticals INC | -2.7% | — | Unchanged |
| 25 | ✓ | Oncothyreon INC | — | EXIT | Sold out |
| 26 | IONS | Ionis Pharmaceuticals INC | — | NEW | New buy |
| 27 | IRWD | Ironwood Pharmaceuticals INC | — | EXIT | Sold out |
| 28 | GLYCEUR | Glycomimetics INC | — | NEW | New buy |
| 29 | ✓ | Cascadian Therapeutics INC | — | NEW | New buy |
| 30 | ✓ | Celator Pharmaceuticals INC | — | EXIT | Sold out |
| 31 | PRTKEUR | Paratek Pharmaceuticals INC | — | NEW | New buy |
| 32 | INFIQ | Infinity Pharmaceuticals INC | — | NEW | New buy |
| 33 | ADROEUR | Chinook Therapeutics INC | — | NEW | New buy |
| 34 | MGNX | Macrogenics INC | — | NEW | New buy |
| 35 | ✓ | Orexigen Therapeutics INC | — | NEW | New buy |
| 36 | ✓ | Loxo Oncology INC | — | EXIT | Sold out |
| 37 | ARRY 3 06-01-20 | Array Bio INC | — | EXIT | Sold out |
| 38 | ✓ | Biota Pharmaceutials INC | — | EXIT | Sold out |
| 39 | PIRSEUR | Pieris Pharmaceuticals INC | — | NEW | New buy |
| 40 | ✓ | Ignyta INC | — | EXIT | Sold out |
| 41 | ✓ | Aviragen Therapeutics INC | — | NEW | New buy |
| 42 | ✓ | Nephrogenex INc | — | EXIT | Sold out |